Attitudes of Clinicians about Screening Head and Neck Cancer Survivors for Lung Cancer Using Low-Dose Computed Tomography.
Kimberly DukesAaron T SeamanRichard M HoffmanAlan J ChristensenNicholas KendellAndrew L SussmanMiriam Vélez-BermúdezRobert J VolkNitin A PagedarPublished in: The Annals of otology, rhinology, and laryngology (2019)
While clinicians feel that LDCT LCS may benefit some HNC survivors, there are barriers both to implementing LCS SDM for these patients in primary care as currently recommended and to integrating it into cancer clinics. Challenges for SDM across settings include a lack of decision aids tailored to patients with cancer histories. Given recommendations to broaden LCS eligibility criteria, more research may be required before refinement of current guidelines.
Keyphrases
- primary care
- low dose
- computed tomography
- end stage renal disease
- young adults
- palliative care
- newly diagnosed
- chronic kidney disease
- clinical practice
- prognostic factors
- peritoneal dialysis
- magnetic resonance imaging
- papillary thyroid
- mental health
- squamous cell carcinoma
- high dose
- positron emission tomography
- smoking cessation
- magnetic resonance
- general practice
- patient reported